Abiopharma

🔍 Jones R. Brent (Executive)

Company: ESAB Corp (ESAB)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 33,978 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-07 | Code: A | Expires: 2029-06-01 | Exercise: 2027-06-01 | equity_swap_involved: 0 | shares_owned_after: 33,978.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 14,210 shares of Employee Stock Options (right to buy) at $102.39 per share (Derivative)
  Date: 2026-05-07 | Code: A | Expires: 2033-05-06 | Exercise: 2027-06-01 | equity_swap_involved: 0 | shares_owned_after: 14,120.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation.
• F2: These restricted stock units vest in three equal, annual installments on the first day of the month following each of the first, second and third anniversaries of the date of grant.
• F3: These employee stock options vest and become exercisable in three equal, annual installments on the first day month following each of the first, second and third anniversaries of the date of grant.